최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기한국임상약학회지 = Korean journal of clinical pharmacy, v.27 no.1, 2017년, pp.1 - 8
The prevalence of diabetes and its related morbidity and mortality are being increased. Despite the advancement of evidence-based pharmacotherapy in the management of diabetes, many patients in our country do not achieve satisfied therapeutic outcomes. Pharmaceutical care service can be defined as a...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
MTM 서비스는 무엇인가? | MTM 서비스는 미국에서 메디케어(Medicare)라고 불리는 연방의료보험을 통하여 제공되는 서비스로, 보험 수혜자인 65세 이상의 고령자를 대상으로 특정 조건을 갖춘 사람에게 제공되는 서비스이다. 이 서비스는 2003년 메디케어현대화법(Medicare Modernization Act, MMA)이 발효된 이후, 고령환자에서 약물유해반응을 감소시키고, 약물관련 비용을 절감하기 위한 목적으로 도입되어 미국의 연방의료보험 제공시스템에 획기적인 변화를 가져온 서비스라고 할 수 있다. | |
MTM 서비스의 긍정적인 영향은 무엇인가? | MTM 서비스는 미국에서 메디케어(Medicare)라고 불리는 연방의료보험을 통하여 제공되는 서비스로, 보험 수혜자인 65세 이상의 고령자를 대상으로 특정 조건을 갖춘 사람에게 제공되는 서비스이다. 이 서비스는 2003년 메디케어현대화법(Medicare Modernization Act, MMA)이 발효된 이후, 고령환자에서 약물유해반응을 감소시키고, 약물관련 비용을 절감하기 위한 목적으로 도입되어 미국의 연방의료보험 제공시스템에 획기적인 변화를 가져온 서비스라고 할 수 있다.8) MTM 서비스에서 약사는 환자와 면담하고 환자의 약물요법에 대해 분석, 평가하여 최적의 치료성과를 나타내기 위해 약물요법 관련 중재를 수행하게 된다. | |
CMM이라는 개념은 언제 제안되었는가? | CMM이라는 개념은 미국에서 2006년, 소비자와 보건의료전문가를 아우르는 ‘환자중심 일차의료협업(The Patient-Centered Primary Care Collaborative, PCPCC)’이라는 단체의 ‘약물관리전문위원회(Medication Management Task Force)’에 의해 공식적으로 제안되었다.8) CMM은 개별 환자들이 적절하고 효과적이며 안전한 약물을 사용하고 있는지를 평가하는 서비스로, 개별 환자의 포괄적이고 체계적인 약물요법 관리를 통하여 약물관련성과(medication-related outcomes)의 향상과, 약물유해반응의 감소 및 의료비용의 절감을 목적으로 하고 있다. |
Hepler CD and Strand LM. Opportunity and responsibility in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
Hammond RW, Schwartz AH, Campbell MJ, et al. Collaborative drug therapy management by pharmacist-2003. Pharmacotherapy 2003; 23:1210-25.
Bond CA and Raehl CL. Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in United States hospitals. Pharmacotherapy 2006;26:735-47.
Bond CA and Raehl CL. Clinical and economic outcomes of pharmacist-managed antiepileptic drug therapy. Pharmacotherapy 2006;26: 369-78.
Gray DR, Garabedian-Ruffalo SM, Chretien SD. Cost-justification of a clinical pharmacist-managed anticoagulation clinic. Drug Intell Clin Pharm 1985;19:575-80.
McGivney MS, Meyer SM, Duncan-Hewitt W, et al. Medication therapy management: Its relationship to patient counseling, disease management, and pharmaceutical care. J Am Pharm Assoc 2007;47:620-28.
American Pharmacists Association and National Association of Chain Drug Stores Foundation. Medication management therapy in pharmacy practice: Core elements of an MTM service model (version 2.0). J Am Pharm Assoc 2008;48:341-53.
McBane SE, Dopp AL, Abe A, et al. Collaborative drug therapy management and comprehensive medcation manangement-2015. Pharmacotherapy 2015;35:e39-e50.
Bluml BM. Definition of medication therapy manangement: development of professionwide consensus. J Am Pharm. Assoc 2005;45:566-72.
American College of Clinical Pharmacy (ACCP). Standards of practice for clinical pharmacists. Pharmacotherapy 2014;34:794-7.
Duckworth W, Abraira C, Mortiz T, et al. VADT Investigators. Glucose control and vascular complications in verterans with type 2 diabetes. N Engl J Med 2009;360:129-39.
Patel A, MacMahon S, Chalmers J, et al. ADVANCE Collaborative Group. Intesive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-72.
Gerstein HC, Miller ME, Byington RP, et al. Action to Control Cardiovascular Risk in Diabetes Study Group. Effect of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-59.
Al Mazroui NR, Kamal MM, Ghabash NM, Yacout TA, Kole PL, McElnay JC. Influence of pharmaceutical care on health outcomes in patients with type 2 diabetes mellitus. Br J Clin Pharmacol 2009; 67:547-57.
Chan CW, Siu SC, Wong CK, Lee VW. A pharmacist care program: positive impact on cardiac risk in patients with type 2 diabetes. J Cardiovasc Pharmacol Ther 2012;17:57-64.
Choe HM, Mitrovich S, Dubay D, Hayward RA, Krein SL, Vijan S. Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. Am J Manag Care 2005;11:253-60.
Chung WW, Chua SS, Lai PS, Chan SP. Effects of a pharmaceutical care model on medication adherence and glycemic control of people with type 2 diabetes. Patient Prefer Adherence 2014;8:1185-94.
Clifford RM, Davis WA, Batty KT, Davis TM. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 2005;28:771-76.
Cohen LB, Taveira TH, Khatana SA, Dooley AG, Pirraglia PA, Wu WC. Pharmacist-led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes. Diabetes Educ 2011;37:801-12.
Farsaei S, Sabzghabaee AM, Zargarzadeh AH, Amini M. Effect of pharmacist-led patient education on glycemic control of type 2 diabetics: a randomized controlled trial. J Res Med Sci 2011;16:43-49.
Jarab AS, Alqudah SG, Mukattash TL, Shattat G, Al-Qirim T. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan. J Manag Care Pharm 2012;18:516-26.
Mahwi TO, Obied KA. Role of the pharmaceutical care in the management of patients with type 2 diabetes mellitus. Int J Pharm Sci Res 2013;4:1363-69.
Mourao AO, Ferreira WR, Martins MA, et al. Pharmaceutical care program for type 2 diabetes patients in Brazil: a randomised controlled trial. Int J Clin Pharm 2013;35:79-86.
Rothman RL, Malone R, Bryant B, et al. A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes. Am J Med 2005;118:276-84.
Scott DM, Boyd ST, Stephan M, Augustine SC, Reardon TP. Outcomes of pharmacist-managed diabetes care services in a community health center. Am J Health Syst Pharm 2006;63:2116-22.
Simpson SH, Majumdar SR, Tsuyuki RT, Lewanczuk RZ, Spooner R, Johnson JA. Effect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes: a randomized controlled trial. Diabetes Care 2011;34:20-26.
Sriram S, Chack LE, Ramasamy R, Ghasemi A, Ravi TK, Sabzghabaee AM. Impact of pharmaceutical care on quality of life in patients with type 2 diabetes mellitus. J Res Med Sci 2011;16(Suppl 1):S412-18.
Wishah RA, Al-Khawaldeh OA, Albsoul AM. Impact of pharmaceutical care interventions on glycemic control and other health-related clinical outcomes in patients with type 2 diabetes: randomized controlled trial. Diabetes Metab Syndr 2015;9:271-76.
Plaster CP, Melo DT, Boldt V, et al. Reduction of cardiovascular risk in patients with metabolic syndrome in a community health center after a pharmaceutical care program of pharmacotherapy follow-up. Braz J Pharm Sci 2012;48:435-46.
Malathy R, Narmadha M, Ramesh S, Alvin JM, Dinesh BN. Effect of a diabetes counseling programme on knowledge, attitude and practice among diabetic patients in Erode district of South India. J Young Pharm 2011;3:65-72.
Korean Diabetes Association. Diabetes Fact Sheet in Korean 2016. Available from: http://www.diabetes.or.kr/pro/news/admin.php?codeadmin&number1331&modevi ew
Smith MA, Nigro SC. The patient-centered medical home. In: Chessman CC, Richardson M, et al, eds. Pharmacotherapy Self-Assessment Program 7th ed. Science and practice of pharmacotherapy. Lenexa, KS: American College of Clinical Pharmacy 2011: 87-102.
MedicalTimes News. 2014-10-15.[Internet] Available at http://www.medicaltimes.com/Users4/News/newsView.html?ID1092591. accessed 25 Mar, 2017.
Nichols-English G. Poirier S. Optimizing adherence to pharmaceutical care plans. J Am Pharm Assoc 2012;40:475-85.
Conrad P. The meaning of medications: Another look at compliance. Soc Sci Med 1985;20:29-37.
Monte SV, Slazak EM, Albenese NP, et al. Clinical and economic impact of a diabetes clinical pharmacy service program in a university and primary care-based collaboration model. J Am Pharm Assoc 2009;49:200-8.
Cranor CW, Bunting BA, Christensen DB. The Asheville Project: Long-term clijncial and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc 2003;43:173-84.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.